Alcohol abuse: Critical pathophysiological processes and contribution to disease burden

Physiology

Volumn 29, Issue 3, 2014, Pages 203-215

  Molina, Patricia E ^a   Gardner, Jason D ^a   Souza Smith, Flavia M ^a   Whitaker, Annie M ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL-RELATED DISORDERS; ALCOHOLISM; ANIMAL; COMPLICATION; COST OF ILLNESS; DRINKING BEHAVIOR; HUMAN; PATHOLOGY;

ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; ALCOHOLISM; ANIMALS; COST OF ILLNESS; HUMANS;

EID: 84900824362     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00055.2013     Document Type: Review

References (132)

1. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108: 218-224, 1995.
2. Addolorato G, Capristo E, Marini M, Santini P, Scognamiglio U, Attilia ML, Messineo D, Sasso GF, Gasbarrini G, Ceccanti M. Body composition changes induced by chronic ethanol abuse: evaluation by dual energy X-ray absorptiometry. Am J Gastroenterol 95: 2323-2327, 2000.
3. Adinoff B, Junghanns K, Kiefer F, Krishnan-Sarin S. Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res 29: 1351-1355, 2005.
4. Aguilar D, Skali H, Moyé LA, Lewis EF, Gaziano JM, Rutherford JD, Hartley LH, Randall OS, Geltman EM, Lamas GA, Rouleau JL, Pfeffer MA, Solomon SD. Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction. J Am Coll Cardiol 43: 2015-2021, 2004.
5. Albano E, Vidali M. Immune mechanisms in alcoholic liver disease. Genes Nutr 5: 141-147, 2010.
6. Aoyama T, Paik YH, Seki E. Toll-like receptor signaling and liver fibrosis. Gastroenterol Res Pract 2010: 192543, 2010.
7. Apte MV, Pirola RC, Wilson JS. Molecular mechanisms of alcoholic pancreatitis. Dig Dis 23: 232-240, 2005.
8. Apte MV, Wilson JS. Alcohol-induced pancreatic injury. Best Pract Res Clin Gastroenterol 17: 593-612, 2003.
9. Atkinson KJ, Rao RK. Role of protein tyrosine phosphoryla-tion in acetaldehyde-induced disruption of epithelial tight junctions. Am J Physiol Gastrointest Liver Physiol 280: G1280-G1288, 2001.
10. Azuma K, Akiyama M, Ebata T, Totsuka M, Hayasaka H. Endogenous endotoxin absorption and the role of intestinal lymphatics. Jpn J Surg 13: 535-539, 1983.
11. Bai Y, Tan Y, Wang B, Miao X, Chen Q, Zheng Y, Cai L. Deletion of angiotensin II type 1 receptor gene or scavenge of superoxide prevents chronic alcohol-induced aortic damage and remodelling. J Cell Mol Med 16: 2530-2538, 2012.
12. Baraona E, Lieber CS. Effects of ethanol on lipid metabolism. J Lipid Res 20: 289-315, 1979.
13. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 115: 209-218, 2005.
14. Berg KM, Kunins HV, Jackson JL, Nahvi S, Chaudhry A, Harris KA, Malik R, Arnsten JH. Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med 121: 406-418, 2008.
15. Bernal CA, Vazquez JA, Adibi SA. Leucine metabolism during chronic ethanol consumption. Metabolism 42: 1084-1086, 1993.
16. Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, Wright PE. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group. Chest 112: 164-172, 1997.
17. Besemer F, Pereira AM, Smit JW. Alcohol-induced Cushing syndrome. Hypercortisolism caused by alcohol abuse. Neth J Med 69: 318-323, 2011.
18. Bikle DD. Alcohol-induced bone disease. World Rev Nutr Diet 73: 53-73, 1973.
19. Boé DM, Nelson S, Zhang P, Bagby GJ. Acute ethanol intoxication suppresses lung chemokine production following infection with Streptococcus pneumoniae. J Infect Dis 184: 1134-1142, 2001.
20. Brieger K, Schiavone S, Miller FJ, Krause KH. Reactive oxygen species: from health to disease. Swiss Med Wkly 142: w13659, 2012.
21. Casini A, Cunningham M, Rojkind M, Lieber CS. Acetalde-hyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 13: 758-765, 1991.
22. Cederbaum AI. Alcohol metabolism. Clin Liver Dis 16: 667-685, 2012.
23. Cederbaum AI. Introduction-serial review: alcohol, oxidative stress and cell injury. Free Radic Biol Med 31: 1524-1526, 2001.
24. Center for Disease Control. Summary Health Statistics for U.S. Adults: National Health Interview Survey, table 27 (Online). Atlanta, GA: Center for Disease Control. http://www.cdc.gov/nchs/fastats/alcohol.htm, 2011.
25. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321: 1493-1495, 2008.
26. Cheng CP, Cheng HJ, Cunningham C, Shihabi ZK, Sane DC, Wannenburg T, Little WC. Angiotensin II type 1 receptor blockade prevents alcoholic cardiomyopathy. Circulation 114: 226-236, 2006.
27. Cicero TJ. Neuroendocrinological effects of alcohol. Annu Rev Med 32: 123-142, 1981.
28. Collins GB, Brosnihan KB, Zuti RA, Messina M, Gupta MK. Neuroendocrine, fluid balance, and thirst responses to alcohol in alcoholics. Alcohol Clin Exp Res 16: 228-233, 1992.
29. Costanzo S, Di Castelnuovo A, Donati MB, Iaco-viello L, de Gaetano G. Alcohol consumption and mortality in patients with cardiovascular disease: a meta-analysis. J Am Coll Cardiol 55: 1339-1347, 2010.
30. Cubero FJ, Nieto N. Kupffer cells and alcoholic liver disease. Rev Esp Enferm Dig 98: 460-472, 2006.
31. De BK, Gangopadhyay S, Dutta D, Baksi SD, Pani A, Ghosh P. Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial. World J Gastroenterol 15: 1613-1619, 2009.
32. Dees WL, Skelley CW, Hiney JK, Johnston CA. Actions of ethanol on hypothalamic and pituitary hormones in prepubertal female rats. Alcohol 7: 21-25, 1990.
33. Doser TA, Turdi S, Thomas DP, Epstein PN, Li SY, Ren J. Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation 119: 1941-1949, 2009.
34. Döring WK, Herzenstiel MN, Krampe H, Jahn H, Pralle L, Sieg S, Wegerle E, Poser W, Ehrenreich H. Persistent alterations of vasopressin and N-terminal proatrial natriuretic peptide plasma levels in long-term abstinent alcoholics. Alcohol Clin Exp Res 27: 849-861, 2003.
35. El Hajj EC, El Hajj MC, Voloshenyuk TG, Mouton AJ, Khoutorova E, Molina PE, Gilpin NW, Gardner JD. Alcohol modulation of cardiac matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs favors collagen accumulation. Alcohol Clin Exp Res 38: 448-456, 2014.
36. Emanuele MA, Emanuele N. Alcohol and the male reproductive system. Alcohol Res Health 25: 282-287, 2001.
37. Farfán Labonne BE, Gutiérrez M, Gómez-Quiroz LE, Konigsberg Fainstein M, Bucio L, Souza V, Flores O, Ortíz V, Hernández E, Kershenobich D, Gutiérrez-Ruíz MC. Acetaldehyde-induced mito-chondrial dysfunction sensitizes hepatocytes to oxi-dative damage. Cell Biol Toxicol 25: 599-609, 2009.
38. Feldstein AE, Bailey SM. Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease. Antioxid Redox Signal 15: 421-424, 2011.
39. Fernández-Checa JC, Kaplowitz N, Colell A, García-Ruiz C. Oxidative stress and alcoholic liver disease. Alcohol Health Res World 21: 321-324, 1997.
40. Fernández-Solá J, Junqué A, Estruch R, Monforte R, Torres A, Urbano-Márquez A. High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med 155: 1649-1654, 1995.
41. Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 43: 163-172, 2009.
42. Frazier TH, Stocker AM, Kershner NA, Marsano LS, McClain CJ. Treatment of alcoholic liver disease. Therap Adv Gastroenterol 4: 63-81, 2011.
43. Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 12: 162-169, 1991.
44. Galli A, Crabb D, Price D, Ceni E, Salzano R, Surrenti C, Casini A. Peroxisome proliferator-ac-tivated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology 31: 101-108, 2000.
45. Gao B, Bataller R. Alcoholic liver disease: patho-genesis and new therapeutic targets. Gastroen-terology 141: 1572-1585, 2011.
46. Ge W, Guo R, Ren J. AMP-dependent kinase and autophagic flux are involved in aldehyde dehy-drogenase-2-induced protection against cardiac toxicity of ethanol. Free Radic Biol Med 51: 1736-1748, 2011.
47. Gilpin NW, Richardson HN, Koob GF. Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol Clin Exp Res 32: 1535-1542, 2008.
48. Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, Bernardi M. Review article: alcoholic liver disease-pathophysiological aspects and risk factors. Aliment Pharmacol Ther 24: 1151-1161, 2006.
49. Guidot DM, Roman J. Chronic ethanol ingestion increases susceptibility to acute lung injury: role of oxidative stress and tissue remodeling. Chest 122: 309S-314S, 2002.
50. Guppy LJ, Crabbe JC, Littleton JM. Time course and genetic variation in the regulation of calcium channel antagonist binding sites in rodent tissues during the induction of ethanol physical dependence and withdrawal. Alcohol Alcohol 30: 607-615, 1995.
51. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epide-miologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 64: 830-842, 2007.
52. Hegedüs L. Thyroid size determined by ultrasound. Influence of physiological factors and non-thyroidal disease. Dan Med Bull 37: 249-263, 1990.
53. Hermann D, Heinz A, Mann K. Dysregulation of the hypothalamic-pituitary-thyroid axis in alcoholism. Addiction 97: 1369-1381, 2002.
54. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15: 2-12, 2000.
55. Israel Y, Walfish PG, Orrego H, Blake J, Kalant H. Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil. Gas-troenterology 76: 116-122, 1979.
56. Jarvis CM, Hayman LL, Braun LT, Schwertz DW, Ferrans CE, Piano MR. Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women. J Cardiovasc Nurs 22: 429-435, 2007.
57. Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells/interfer-on-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 134: 248-258, 2008.
58. Kelly KN, Kelly C. Pattern and cause of fractures in patients who abuse alcohol: what should we do about it? Postgrad Med J 89: 578-583, 2013.
59. Keshavarzian A, Fields JZ, Vaeth J, Holmes EW. The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gas-troenterol 89: 2205-2211, 1994.
60. Khanna JM, Israel Y. Ethanol metabolism. Int Rev Physiol 21: 275-315, 1980.
61. Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R, Gao B. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52: 1291-1300, 2010.
62. Kim SD, Beck J, Bieniarz T, Schumacher A, Piano MR. A rodent model of alcoholic heart muscle disease and its evaluation by echocardiography. Alcohol Clin Exp Res 25: 457-463, 2001.
63. Kimble RB. Alcohol, cytokines, and estrogen in the control of bone remodeling. Alcohol Clin Exp Res 21: 385-391, 1997.
64. Kodama S, Saito K, Tanaka S, Horikawa C, Saito A, Heianza Y, Anasako Y, Nishigaki Y, Yachi Y, Iida KT, Ohashi Y, Yamada N, Sone H. Alcohol consumption and risk of atrial fibrillation: a meta-analysis. J Am Coll Cardiol 57: 427-436, 2011.
65. Lang CH, Frost RA, Kumar V, Wu D, Vary TC. Impaired protein synthesis induced by acute alcohol intoxication is associated with changes in eIF4E in muscle and eIF2B in liver. Alcohol Clin Exp Res 24: 322-331, 2000.
66. LeCapitaine NJ, Wang ZQ, Dufour JP, Potter BJ, Bagby GJ, Nelson S, Cefalu WT, Molina PE. Disrupted anabolic and catabolic processes may contribute to alcohol-accentuated SAIDS-associ-ated wasting. J Infect Dis 204: 1246-1255, 2011.
67. Leggio L, Malandrino N, Ferrulli A, Cardone S, Miceli A, Gasbarrini G, Capristo E, Addolorato G. Is cortisol involved in the alcohol-related fat mass impairment? A longitudinal clinical study. Alcohol Alcohol 44: 211-215, 2009.
68. Lester R, Van Thiel DH. Gonadal function in chronic alcoholic men. Adv Exp Med Biol 85A: 399-413, 1977.
69. Lieber CS. Relationships between nutrition, alcohol use, and liver disease. Alcohol Res Health 27: 220-231, 2003.
70. Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health 27: 209-219, 2003.
71. Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut 58: 704-720, 2009.
72. Michel L, Serrano A, Malt RA. Mallory-Weiss syndrome. Evolution of diagnostic and therapeutic patterns over two decades. Ann Surg 192: 716-721, 1980.
73. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 291: 1238-1245, 2004.
74. Molina P, Fan J, Gelato M, Lang C, Abumrad N. Modulation of insulin-like growth factor-I: A specific role for vitamin B1 (thiamine). J Nutr Biochem 7: 207-213, 1996.
75. Molina PE, Happel KI, Zhang P, Kolls JK, Nelson S. Focus on: alcohol and the immune system. Alcohol Res Health 33: 97-108, 2010.
76. Molina PE, Hoek JB, Nelson S, Guidot DM, Lang CH, Wands JR, Crawford JM. Mechanisms of alcohol-induced tissue injury. Alcohol Clin Exp Res 27: 563-575, 2003.
77. Molina PE, McNurlan M, Rathmacher J, Lang CH, Zambell KL, Purcell J, Bohm RP, Zhang P, Bagby GJ, Nelson S. Chronic alcohol accentuates nutritional, metabolic, and immune alterations during asymptomatic simian immunodeficiency virus infection. Alcohol Clin Exp Res 30: 2065-2078, 2006.
78. Moss M, Bucher B, Moore FA, Moore EE, Parsons PE. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 275: 50-54, 1996.
79. Mueller S, Millonig G, Seitz HK. Alcoholic liver disease and hepatitis C: a frequently underestimated combination. World J Gastroenterol 15: 3462-3471, 2009.
80. National Institute on Drug Abuse. Trends and Statistics; Cost of Substance Abuse (Online). Bethesda, MD: National Inst. on Drug Abuse. http://www.drugabuse.gov/related-topics/trends-statistics, 2012.
81. Nelson S, Summer W, Bagby G, Nakamura C, Stewart L, Lipscomb G, Andresen J. Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J Infect Dis 164: 901-906, 1991.
82. Nicolás JM, Fernández-Sola J, Fatjó F, Casamit-jana R, Bataller R, Sacanella E, Tobías E, Badía E, Estruch R. Increased circulating leptin levels in chronic alcoholism. Alcohol Clin Exp Res 25: 83-88, 2001.
83. Nomura S, Pittman CS, Chambers JB, Buck MW, Shimizu T. Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis. J Clin Invest 56: 643-652, 1975.
84. Orman ES, Odena G, Bataller R. Alcoholic liver disease: pathogenesis, management, and novel targets for therapy. J Gastroenterol Hepatol 28, Suppl 1: 77-84, 2013.
85. Pacy PJ, Preedy VR, Peters TJ, Read M, Halliday D. The effect of chronic alcohol ingestion on whole body and muscle protein synthesis: a stable isotope study. Alcohol Alcohol 26: 505-513, 1991.
86. Parry CD, Patra J, Rehm J. Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction 106: 1718-1724, 2011.
87. Piano MR. Alcoholic cardiomyopathy: incidence, clinical characteristics, pathophysiology. Chest 121: 1638-1650, 2002.
88. Piano MR, Rosenblum C, Solaro RJ, Schwertz D. Calcium sensitivity and the effect of the calcium sensitizing drug pimobendan in the alcoholic isolated rat atrium. J Cardiovasc Pharmacol 33: 237-242, 1999.
89. Poli G, Parola M. Oxidative damage and fibro-genesis. Free Radic Biol Med 22: 287-305, 1997.
90. Polikandriotis JA, Rupnow HL, Elms SC, Clempus RE, Campbell DJ, Sutliff RL, Brown LA, Guidot DM, Hart CM. Chronic ethanol ingestion increases superoxide production and NADPH oxidase expression in the lung. Am J Respir Cell Mol Biol 34: 314-319, 2006.
91. Preedy VR, Peters TJ, Patel VB, Miell JP. Chronic alcoholic myopathy: transcription and transla-tional alterations. FASEB J 8: 1146-1151, 1994.
92. Preedy VR, Salisbury JR, Peters TJ. Alcoholic muscle disease: features and mechanisms. J Pathol 173: 309-315, 1994.
93. Pritchard MT, McMullen MR, Stavitsky AB, Cohen JI, Lin F, Medof ME, Nagy LE. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 132: 1117-1126, 2007.
94. Raskin NH, Sokoloff L. Enzymes catalysing ethanol metabolism in neural and somatic tissues of the rat. J Neurochem 19: 273-282, 1972.
95. Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T, Parry CD, Patra J, Popova S, Poznyak V, Roerecke M, Room R, Samokhvalov AV, Taylor B. The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction 105: 817-843, 2010.
96. Ren J, Davidoff AJ, Brown RA. Acetaldehyde depresses shortening and intracellular Ca transients in adult rat ventricular myocytes. Cell Mol Biol (Noisy-le-grand) 43: 825-834, 1997.
97. Richardson HN, Lee SY, O'Dell LE, Koob GF, Rivier CL. Alcohol self-administration acutely stimulates the hypothalamic-pituitary-adrenal axis, but alcohol dependence leads to a dampened neuroendocrine state. Eur J Neurosci 28: 1641-1653, 2008.
98. Riveros-Rosas H, Julian-Sanchez A, Pinã E. Enzy-mology of ethanol and acetaldehyde metabolism in mammals. Arch Med Res 28: 453-471, 1997.
99. Roberts DM. Chronic gastritis, alcohol, and non-ulcer dyspepsia. Gut 13: 768-774, 1972.
100. Rogers CQ, Ajmo JM, You M. Adiponectin and alcoholic fatty liver disease. IUBMB Life 60: 790-797, 2008.
101. Romas E, Gillespie MT, Martin TJ. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30: 340-346, 2002.
102. Romics L, Mandrekar P, Kodys K, Velayudham A, Drechsler Y, Dolganiuc A, Szabo G. Increased lipopolysaccharide sensitivity in alcoholic fatty livers is independent of leptin deficiency and toll-like receptor 4 (TLR4) or TLR2 mRNA expression. Alcohol Clin Exp Res 29: 1018-1026, 2005.
103. Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med 352: 596-607, 2005.
104. Sampson HW, Perks N, Champney TH, DeFee B. Alcohol consumption inhibits bone growth and development in young actively growing rats. Alcohol Clin Exp Res 20: 1375-1384, 1996.
105. Saville PD. Alcohol-related skeletal disorders. Ann NY Acad Sci 252: 287-291, 1975.
106. Schaffert CS, Duryee MJ, Hunter CD, Hamilton BC, DeVeney AL, Huerter MM, Klassen LW, Thiele GM. Alcohol metabolites and lipopolysac-charide: roles in the development and/or progression of alcoholic liver disease. World J Gastroenterol 15: 1209-1218, 2009.
107. Schneider A, Singer MV. Alcoholic pancreatitis. Dig Dis 23: 222-231, 2005.
108. Setshedi M, Wands JR, Monte SM. Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev 3: 178-185, 2010.
109. Soszynski PA, Frohman LA. Inhibitory effects of ethanol on the growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-I axis in the rat. Endocrinology 131: 2603-2608, 1992.
110. Souza-Smith FM, Kurtz KM, Molina PE, Breslin JW. Adaptation of mesenteric collecting lymphatic pump function following acute alcohol intoxication. Microcirculation 17: 514-524, 2010.
111. Spencer H, Rubio N, Rubio E, Indreika M, Seitam Chronic alcoholism A. Frequently overlooked cause of osteoporosis in men. Am J Med 80: 393-397, 1986.
112. Stranges S, Wu T, Dorn JM, Freudenheim JL, Muti P, Farinaro E, Russell M, Nochajski TH, Trevisan M. Relationship of alcohol drinking pattern to risk of hypertension: a population-based study. Hypertension 44: 813-819, 2004.
113. Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 16: 1321-1329, 2010.
114. Szabo G, Mandrekar P, Oak S, Mayerle J. Effect of ethanol on inflammatory responses. Implications for pancreatitis. Pancreatology 7: 115-123, 2007.
115. Taivainen H, Laitinen K, Tähtelä R, Kilanmaa K, Välimäki MJ. Role of plasma vasopressin in changes of water balance accompanying acute alcohol intoxication. Alcohol Clin Exp Res 19: 759-762, 1995.
116. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 17: 1-14, 2005.
117. Teschner M, Schaefer RM, Weissinger F, Kulzer P, Duelk MJ, Peter G, Heidland A. Chronic etha-nol ingestion enhances catabolism and muscle protease activity in acutely uremic rats. Nephron 50: 338-344, 1988.
118. Teyssen S, González-Calero G, Korn A, Singer MV. Action of ethanol and some alcoholic beverages on gastric acid secretion in anaesthetized rats. Alcohol Alcohol 32: 23-31, 1997.
119. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, Kambadur R. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275: 40235-40243, 2000.
120. Tilg H, Jalan R, Kaser A, Davies NA, Offner FA, Hodges SJ, Ludwiczek O, Shawcross D, Zoller H, Alisa A, Mookerjee RP, Graziadei I, Datz C, Trauner M, Schuppan D, Obrist P, Vogel W, Williams R. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 38: 419-425, 2003.
121. Vanderschueren D, Vandenput L, Boonen S, Lind-berg MK, Bouillon R, Ohlsson C. Androgens and bone. Endocr Rev 25: 389-425, 2004.
122. Vary TC, Frost RA, Lang CH. Acute alcohol intoxication increases atrogin-1 and MuRF1 mRNA without increasing proteolysis in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 294: R1777-R1789, 2008.
123. Vendemiale G, Grattagliano I, Altomare E, Serviddio G, Portincasa P, Prigigallo F, Palasciano G. Mitochondrial oxidative damage and myocar-dial fibrosis in rats chronically intoxicated with moderate doses of ethanol. Toxicol Lett 123: 209-216, 2001.
124. Vonlaufen A, Wilson JS, Pirola RC, Apte MV. Role of alcohol metabolism in chronic pancreatitis. Alcohol Res Health 30: 48-54, 2007.
125. Walsh CR, Larson MG, Evans JC, Djousse L, Ellison RC, Vasan RS, Levy D. Alcohol consumption and risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 136: 181-191, 2002.
126. Wang HJ, Zakhari S, Jung MK. Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development. World J Gas-troenterol 16: 1304-1313, 2010.
127. Whitaker AM, Sulzer JK, Molina PE. Augmented central nitric oxide production inhibits vasopres-sin release during hemorrhage in acute alcohol-intoxicated rodents. Am J Physiol Regul Integr Comp Physiol 301: R1529-R1539, 2011.
128. Wyatt TA, Sisson JH. Chronic ethanol downregu-lates PKA activation and ciliary beating in bovine bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 281: L575-L581, 2001.
129. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 38: 1112-1117, 2001.
130. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenter-ology 144: 1252-1261, 2013.
131. Zhang P, Nelson S, Summer WR, Spitzer JA. Acute ethanol intoxication suppresses the pulmonary inflammatory response in rats challenged with intrapulmonary endotoxin. Alcohol Clin Exp Res 21: 773-778, 1997.
132. Zoeller RT, Fletcher DL, Simonyl A, Rudeen PK. Chronic ethanol treatment reduces the responsiveness of the hypothalamic-pituitary-thyroid axis to central stimulation. Alcohol Clin Exp Res 20: 954-960, 1996.